In the rapid-clearing osteosarcoma model with intact cognitive behavioral performance, neither GD2- nor B7H3-targeting, tumor-clearing CAR T cell therapy resulted in an increase in microglial number or reactivity in any of the regions evaluated (Figure 3J–3L; S2J–S2L). The gene discussed is CD276; the disease is neoplasm.